Denosumab 60 mg/mL, 120 mg/1.7 mL Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 60 mg/mL, 120 mg/1.7 mL
Reference Brands: Prolia, Xgeva
Category: Osteoporosis
Denosumab is available as 60 mg (Prolia) and 120 mg (Xgeva) prefilled syringes for osteoporosis and cancer-related bone conditions. Ideal for global pharma B2B sourcing.
Product Description: Denosumab is a leading RANKL-inhibiting monoclonal antibody used in the treatment of osteoporosis, cancer-related bone loss, and bone metastases. Available as a 60 mg/mL prefilled syringe (Prolia®) for biannual dosing and 120 mg/1.7 mL (Xgeva®) for monthly administration, Denosumab offers effective and long-acting bone protection. Trusted globally under Amgen's Prolia and Xgeva brands, it is approved across the US and EU. Denosumab is manufactured in GMP-certified facilities and is available for B2B pharmaceutical distribution, including hospitals and oncology clinics. Contact us for bulk export, COAs, and regulatory documentation.
Denosumab — third party manufacturing & bulk supply
Denosumab 60 mg/mL, 120 mg/1.7 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Denosumab is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Denosumab listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Denosumab →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Abaloparatide
Strength:
80 mcg
Form: injection (prefilled syringe)
Reference Brands: Tymlos (USA), Eladynos (EU)
View Details
Pamidronate Disodium
Strength:
15 mg, 30 mg, 60 mg, 90 mg
Form: Injection
Reference Brands: Aredia (USA/EU)
View Details
Calcitonin Salmon
Strength:
100 IU/mL, 200 IU/mL
Form: Injection / nasal spray
Reference Brands: Fortical (USA), Miacalcin (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
